tiprankstipranks
RedHill Biopharma Shareholders Approve Key Resolutions
Company Announcements

RedHill Biopharma Shareholders Approve Key Resolutions

RedHill Biopharma (RDHL) has released an update.

Pick the best stocks and maximize your portfolio:

RedHill Biopharma Ltd. recently held its Annual General Meeting, with shareholders approving all proposed resolutions. Key decisions include the appointment of Kesselman & Kesselman as auditors for 2024, the re-election of two board members alongside a new member, and the approval of restricted share units for non-executive directors, the CEO, and the Chief Commercial Officer.

For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskRedHill Biopharma Advances Opaganib for GI-ARS Treatment
TheFlyRedHill Biopharma’s opaganib shows radioprotective activity in study
TipRanks Auto-Generated NewsdeskRedHill Biopharma Wins $8 Million Court Judgment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App